Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  
August 20, 2020

CLL Society 2020 Patient Survey: MRD Testing and Limited Duration Therapy

CLL Society is asking for patient and caregiver participation in a survey which will help us learn about knowledge, attitudes, and preferences about MRD (measurable residual disease or minimal residual disease) and limited duration (also known as fixed duration) therapies. Our goal is to learn more about what our patients know and think so we can best serve you in the future. Please take a few minutes to complete this important survey.

Your survey responses will be treated in confidence and used only for statistical/research purposes. If you wish to participate, you are entitled to all rights included in the General Data Protection Regulation (GDPR), such as the right to access your information. You can withdraw your consent for any future processing of your personal information at any time by sending an email to support@cllsociety.org.

The data collected will be anonymized and combined with other people’s responses, so that identification of individual respondents will not be possible. The data will be sent directly to the nonprofit CLL Society for statistical processing.

Proceed to the Survey

About the author

Brad Hedrick

Related posts
Study Announcement: The Experiences of People with Chronic Lymphocytic Leukemia
February 12, 2021
CLL/SLL Patient Survey for Lymphoma Canada
January 27, 2020
CLL Society Poster Presentation from ASH 2016
April 5, 2017
The CLL Tribune Q2 2016 Reader Poll Results
June 29, 2016
Reader Poll Results Q1 2016
March 29, 2016
The CLL Tribune Q3 2015 Reader Poll Results
December 29, 2015
Recent News
  • Chronic Lymphocytic Leukemia (CLL) Patients and Protection against COVID-19: Passive and Active Immunity, Monoclonal Antibodies and Vaccines
    February 25, 2021
  • Trials Studying the Safety and Immune Response of Chronic Lymphocytic Leukemia (CLL) Patients Receiving the COVID-19 Vaccines
    February 12, 2021
  • FDA approves lisocabtagene maraleucel (liso-cel or JCAR-017) a CAR-T cell therapy for relapsed or refractory large B-cell lymphoma
    February 6, 2021
Conference Coverage
  • ASH 2020: Dr. Paolo Ghia Discusses the ASCEND Study – Acalabrutinib vs. Idelalisib + Rituximab or Bendamustine + Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia or CLL
    March 1, 2021
  • ASH 2020: Dr. Alexey Danilov Discusses Chronic Lymphocytic Leukemia (CLL) Patients Participating in Clinical Trials During the COVID-19 Pandemic
    February 25, 2021
  • ASH 2020: Dr. Jennifer Brown on combination duvelisib + venetoclax for patients with relapsed/refractory chronic lymphocytic leukemia (CLL)
    February 20, 2021
  • ASH 2020: Dr. Meghan Thompson Interview – Venetoclax Retreatment of Chronic Lymphocytic Leukemia (CLL) Patients after a Previous Venetoclax-Based Regimen
    February 19, 2021
  • ASH 2020: Dr. Meghan Thompson – Can APR-246 Restore the Wild-Type Function of the P53 Gene in Chronic Lymphocytic Leukemia (CLL)
    February 12, 2021
  • ASH 2020: Dr. Jennifer Brown on cardiovascular events in patients with chronic lymphocytic leukemia (CLL) treated with acalabrutinib
    February 8, 2021

Chronic Lymphocytic Leukemia Toolbox

  • Abbreviations & Acronyms
  • Ask The Doctor
  • Ask The Pharmacist
  • Ask The Laboratory Scientist
  • Ask the Palliative Care/Hospice Doctor
  • Build-A-Team
  • CLL Doctors
  • CLL Glossary
  • CLL Links
  • Keeping Track Of
    Lab Results
  • Normal Lab Values
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Testing
      • Diagnostic Testing
      • Test Before Treat™
      • MRD & Disease Monitoring
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Survey Central
      • CLL Society Surveys
      • Paid Research Opportunities
      • Other Surveys
    • Becoming Informed
    • Caregivers
    • Financial Assistance
    • Impact of Diagnosis
    • Planning Ahead
    • Support
    • Taking Charge
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2020 Conferences
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Support Groups
    • Support Group Calendar
    • CLL Bloodline Monthly Support Group Newsletter
    • CLL Society Patient & Caregiver Educational Forums
    • Upcoming CLL Patient Education Programs
    • On Demand Education
    • Leader Resources
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • The CLL Society Tribune Index
      • Ask & Tell
      • Ask The Doctor
      • Ask The Lab Scientist
      • Ask the Hospice/Palliative Care Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
2021 Industry Advisory Council

Copyright 2021 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





This site uses cookies: Find out more.